Home Newsfeeds Corbus Pharmaceuticals Q3 EPS $(0.07) Down From $(0.02) YoY

Corbus Pharmaceuticals Q3 EPS $(0.07) Down From $(0.02) YoY

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.07) per share. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.07) per share. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.

Media
News

Tesla EV Batter Supplier CATL Wants to Catch Up to Peers, Gets In Solar Panels

By Anusuya Lahiri

May 26, 7:45 AM

Chinese EV battery producer Contemporary Amperex Technology Co Ltd is researching the development of perovskite cells to drive new improvements…

BYDDF

Molekule And Aura Expand In Global Education Market With Multiple Deployments And Orders; Education Industry Sales Reach Nearly $4M

By Benzinga Newsdesk

April 28, 9:09 AM

Education industry sales reach nearly $4MInstalled base hits over 11,000 air purifiers in schools, including some of the largest school districts in the U.S., eliminating SARS-CoV-2, RSV, H1N1 Flu Virus, bacteria and

MKUL